Home/Mycovia Pharmaceuticals/Patrick Jordan, MA, MBA
PJ

Patrick Jordan, MA, MBA

Chairman

Mycovia Pharmaceuticals

Mycovia Pharmaceuticals Pipeline

DrugIndicationPhase
VIVJOA (oteseconazole)Recurrent Vulvovaginal Candidiasis (RVVC)Approved